AGRANULOCYTOSIS ASSOCIATED WITH SULFASALAZINE THERAPY

被引:12
作者
COCHRANE, P [1 ]
ATKINS, P [1 ]
EHSANULLAH, S [1 ]
机构
[1] WALTON HOSP, LIVERPOOL, ENGLAND
关键词
D O I
10.1136/pgmj.49.575.669
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:669 / 672
页数:4
相关论文
共 14 条
[1]  
BOTTIGER L. E., 1963, GASTROENTEROLOGIA [BASEL], V100, P33
[2]  
COLLINS JR, 1968, J SO MEDICAL ASSOCIA, V61, P354
[3]  
DEGRUCHY GC, 1970, CLINICAL HAEMATOLOGY
[4]  
EVANS DAP, 1964, J LAB CLIN MED, V63, P394
[5]   STUDIES OF THE BONE MARROW IN IMMUNOLOGICAL GRANULOCYTOPENIA - FOLLOWING ADMINISTRATION OF SALICYLAZOSULFAPYRIDINE [J].
EVANS, RS ;
FORD, WP .
ARCHIVES OF INTERNAL MEDICINE, 1958, 101 (02) :244-251
[6]  
GARDNER MD, 1964, JAMA-J AM MED ASSOC, V190, P71
[7]   AN ASSESSMENT OF PREDNISONE, SALAZOPYRIN, AND TOPICAL HYDROCORTISONE HEMISUCCINATE USED AS OUT-PATIENT TREATMENT FOR ULCERATIVE COLITIS [J].
LENNARDJONES, JE ;
LONGMORE, AJ ;
NEWELL, AC ;
WILSON, CWE ;
JONES, FA .
GUT, 1960, 1 (03) :217-222
[8]  
MISIEWICZ JJ, 1965, LANCET, V1, P185
[9]   SIMPLIFIED METHOD FOR DETERMINING ACETYLATOR PHENOTYPE [J].
SCHRODER, H .
BRITISH MEDICAL JOURNAL, 1972, 3 (5825) :506-&
[10]   ACETYLATOR PHENOTYPE AND ADVERSE EFFECTS OF SULFASALAZINE IN HEALTHY SUBJECTS [J].
SCHRODER, H ;
EVANS, DAP .
GUT, 1972, 13 (04) :278-+